Protein kinase C isozymes as therapeutic targets for treatment of human cancers.
about
Protein kinase Cα promotes cell migration through a PDZ-dependent interaction with its novel substrate discs large homolog 1 (DLG1)Inhibition of PKCα reduces the ability of migration of kidney cancer cells but has no impact on cell apoptosisProtein kinase Cι expression and oncogenic signaling mechanisms in cancer.Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanismA Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancieProtein kinase Cδ promotes proliferation and induces malignant transformation in skeletal muscleProtein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma.Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors.The chromosome 3q26 OncCassette: A multigenic driver of human cancer.Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesisProtein kinase Calpha: disease regulator and therapeutic target.Atypical protein kinase Cι as a human oncogene and therapeutic target.Knockout mouse models of insulin signaling: Relevance past and futureRACK-1 overexpression protects against goniothalamin-induced cell death.Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion.
P2860
Q30010216-95A6BB25-38A4-4437-B706-A224B56C5317Q33723921-2FD3099D-5F04-4661-B582-A588EF908AE4Q34787801-4850288F-AAC0-4C0B-A9DC-C948F4579E03Q34981351-E8BE8FD8-4CE7-4B7B-BE01-1C7815B10F27Q35000494-979D4430-128B-40BA-BE2C-40217F48A794Q35531322-2B17304C-4D5F-4373-99A6-C05D806739B2Q35987724-537E9BC8-9D0D-43D7-B292-522BD18EA9FEQ36294936-7E045EBA-3EE9-45F7-B562-95853113B3B4Q36510237-4949F15E-E8A2-462C-A6ED-5C393633B455Q37491175-8C92404E-02E3-4CC3-B697-BCD3AEA473CBQ37520978-12B623A0-6F93-449C-AE82-63335D70E150Q37647208-46CE721C-277A-4758-8D99-68B2E137A21BQ38162656-31904E78-7A6E-47C0-9122-D7315F1BB58AQ38205763-B78E03A3-E9F9-4793-96F3-4F54BDC83AE5Q39805365-BBB07055-B5D6-4EDA-BF64-1D60EFBF0B66Q42511544-2C9A4881-A7F9-46D4-96A9-5193B06CF6F6
P2860
Protein kinase C isozymes as therapeutic targets for treatment of human cancers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Protein kinase C isozymes as therapeutic targets for treatment of human cancers.
@en
type
label
Protein kinase C isozymes as therapeutic targets for treatment of human cancers.
@en
prefLabel
Protein kinase C isozymes as therapeutic targets for treatment of human cancers.
@en
P2860
P1476
Protein kinase C isozymes as therapeutic targets for treatment of human cancers.
@en
P2093
Alan P Fields
Nicole R Murray
P2860
P304
P356
10.1016/J.ADVENZREG.2007.11.014
P577
2008-03-18T00:00:00Z